Many of us have pictures of intracellular signalling pathways on the walls where we work. These diagrams condense data from a wide variety of biochemical and cell biological experiments in different cell types into a web of interactions, helping us to see the individual genes that are the focus of our research in a wider context. Like the friezes on Roman arches and columns, they also serve to remind us of our most prized molecular biological conquests. Are such networks true to life? If our goal is to understand the function of proteins in a cellular context, it would be better to be able to overlay multiple networks, each one of which summarized genome-wide loss of function data from a single cell type under well-defined conditions. A few years ago such an analysis seemed a distant dream. With the discovery of dsRNA-mediated interference (RNAi), the data is coming in fast.
RNAi is a highly conserved cellular system that enables a wide range of eukaryotes to respond to the presence of dsRNA by targeting homologous mRNAs for destruction (Hannon, 2002) . Although eukaryotes use this machinery to regulate gene expression and as an antiviral defense (Grosshans and Slack, 2002) , it presents molecular biologists with a remarkable new tool with which to dissect the function of genes identified by genomic sequencing (Table 1) . A large number of groups have seized upon RNAi technology and the expanding zoo of genomic sequences to design large collections of dsRNAs that target genes on a genome-wide scale in Caenorhabditis elegans, Drosophila, mouse and human cells and in Arabidopsis Waterhouse and Helliwell, 2003; Berns et al., 2004; Boutros et al., 2004; Paddison et al., 2004) . Largescale RNAi screens have already reproduced many previously hard-won genetic discoveries, and have identified new genes that appear to function in wellstudied biological processes, such as p53-mediated senescence, cell morphogenesis, cytokinesis, phagocytosis and signalling (Somma et al., 2002; Kiger et al., 2003; Lum et al., 2003; Pearson et al., 2003; Berns et al., 2004) .
Classical genetic screens for genes with important cell biological functions in animals have always been limited by the fact that such genes are required repeatedly throughout development, so that loss of function mutations in these genes can be lethal. Although ingenious genetic tricks have been devised to help overcome this hurdle, for example, sensitizing animals to mutations in the heterozygous condition (Karim et al., 1996) and generating clones of homozygous mutant cells in a wild-type tissue background (Chou and Perrimon, 1996; Stowers and Schwarz, 1999) , cell biological screens remain something of a challenge. Overnight, however, RNAi has made a wide range of similar phenomena genetically tractable in cell culture. This is significant because decades of research have optimized cell culture systems for the study of many different cell biological processes, and because homogenous populations of immortalized cells can also be rapidly expanded so that proteomic, microarray, cell biological and functional data can be generated and crosscorrelated (Agaisse et al., 2003; Forler et al., 2003) . Moreover, the analysis in human cells in culture is often an essential bridge to understanding cell biological processes in humans and in human disease. Thus, although we might ultimately hope to study gene function in cells within a developmental context, RNAi in cell culture now provides an excellent model genetic system for the study of many fundamental problems in cell biology.
It is through its use in large-scale screens and selection experiments that RNAi is likely to have the greatest impact on cell biology. In screens, cells, tissues or whole animals are exposed to a one or two dsRNA species (e.g. in 384-well plates). Phenotypes are then followed as the expression of the corresponding gene(s) decays over time. In contrast, in a selection experiment, cells expressing a library of small dsRNAs are grown en mass. After a period of selection, surviving cells are (Berns et al., 2004; Paddison et al., 2004) . In both cases, the use of RNAi has a number of advantages over random mutagenesis. First, the bottleneck in classical genetics has always been the difficulty of identifying the mutation responsible for a given phenotype. Since each dsRNA immediately identifies the corresponding gene, RNAi screening effectively combines forward and reverse genetics. Second, RNAi screens can be used to assay the involvement of large sets of genes in a process in a systematic fashion. This reduces the bias that always accompanies mutagenesis experiments and makes it possible to design focused screens that target particular subsets of genes based on their sequence. It is possible, for example, to screen an RNAi library that targets the full set of protein kinases to identify the kinase responsible for the phosphorylation of a known phospho-protein. As dsRNA libraries become better validated, it should even be possible to make such screens comprehensive, so that the function of all genes identified in the genome can be studied in parallel, as is possible, using defined sets of deletion mutants in yeast (Giaever et al., 2002) . Although first-generation RNAi libraries generate large numbers of false negatives, as well as occasional false positives, confidence limits will become better defined each time any given dsRNA library is used. In addition, as we learn more about the mechanism of dsRNA-mediated interference, it will be possible to build potent and specific RNAi libraries for this purpose that contain multiple, nonoverlapping dsRNAs that target each annotated mRNA in the genome. Finally, one of the unique features of dsRNAmediated gene silencing is that the phenotype arises over time as protein levels are gradually depleted following RNAi-induced mRNA degradation (Hannon, 2002) . Although phenotypes arising from the progressive loss of protein can be more difficult to interpret than those induced by sudden gene inactivation (Kanemaki et al., 2003) . This potential weakness of the technology can be harnessed so that the function of essential and nonessential genes can be analysed at a range of thresholds at different times following mRNA degradation (Kiger et al., 2003) , mimicking an allelic series of mutations.
The discovery of RNAi coincided with the explosion of genomic sequencing projects, just when the need for functional genomic tools became pressing. Given the ease and speed at which a partial loss of function phenotype can be generated for any gene using RNAi in cell culture, genome-wide RNAi screens can now be used to refine our understanding of the genome, for example, by enabling comparisons between gene function and their position on chromosomes or their evolutionary history . In addition, RNAi can be used to clarify the exonic structure of genes and to define functions for specific splice variants, since RNAi only targets the mature mRNA for destruction. The use of RNAi, or any other loss of function strategy, to study the genome as a whole, however, is limited by the fact that the majority of single genes can be deleted from flies, worms or yeast without generating a visible phenotype. Thus, the function of most of the genes visible to natural selection cannot be studied by such methods in the lab. Since biological systems need to be able to withstand genetic and The dsRNA inducing a loss of function phenotype immediately identifies the corresponding gene
The rate-limiting step in a classical genetic screen based on random mutagenesis is identification of the mutant locus Bar-coded RNAi vectors can be used to follow populations of cells expressing different siRNAs Screens using sets of deletion mutants have many of the benefits of RNAi screens. It can prove difficult, however, to use them to study the function of essential genes RNAi can be used to target any RNA identified in the genome, enabling the rational design of comprehensive RNAi libraries
In screens using random mutagenesis, bias can be minimized by taking the screen 'to saturation', when multiple independent mutant alleles are identified RNAi libraries are limited by the state of genome annotation Such screens are not limited by the state of genome annotation and can identify loci that do not code for mRNAs RNAi targets the mRNA and so can be used to remove individual splice variants and maternally loaded mRNAs Random mutagenesis yields a wide variety of mutations, including loss of function, gain of function and conditional mutants Protein levels slowly decline over time following induction of RNAi and some detectable protein usually remains. By changing the time course, a variety of loss of function phenotypes can be studied Drugs and conditional mutants can be used to rapidly and reversibly inactivate gene functions RNAi can induce off target miRNA and RNAi effects and the interferon response. Specificity is easily controlled for by using two or more independent dsRNAs to target each gene Many compounds and dominant negatives lack high specificity, but can be used to target large families of related genes
Combinations of dsRNAs can be used to simultaneously target 2-3 mRNAs Modifier screens can be carried out to focus a screen on a single pathway or system. In organisms other than yeast, it is hard to study gene interactions systematically RNAi brings a loss of function analysis to many well-defined cell culture systems and can be used in eukaryotes for which classical genetic tools are lacking, enabling cross-species comparisons It is difficult to establish a new system amenable to genetic analysis Ectopic gene expression can be used to identify functionally redundant genes and genes outside of their normal expression domain, and allows genes from one organism to be expressed in another. It is ideal for studying oncogenes or viral genes RNAi in a postmodern, postgenomic era B Baum and G Craig environmental noise, it has been suggested that the functions of many individual genes may be masked in laboratory animals by the action of other genes and pathways (Hartwell, 2004 ). An implication of this hypothesis is that functional interactions can be revealed using combinatorial genetics (Tong et al., 2004) . Although such studies are impossible in practise in most animals, they can be carried out relatively easily and systematically in RNAi screens by combining two or three dsRNAs at a time. This type of analysis can then be used to screen for functional interactions: to identify synthetic lethal genes (Tong et al., 2004) , genetic modifiers of a specific phenotype (Kiger et al., 2003) and to order genetic pathways as part of an epistasis analysis. In a similar vein, genome-wide RNAi screens can be carried out under diverse conditions to reveal how a cell's genetic circuitry is altered in response to changes in the environment (Giaever et al., 2002) , genetic background (Simmer et al., 2003) or cell type. As an example of this, two recent RNAi studies compared morphologically distinct Drosophila haemocyte cell lines and found that most lethal dsRNAs affected both cell lines, whereas dsRNAs affecting cell morphology usually exhibited cell-type specific phenotypes (Boutros et al., 2004; Kiger et al., 2003) . In the near future, as data from hundreds of genome-wide screens becomes available, it will be possible to extend this type of analysis to make more sophisticated comparisons between cell-type and environmental-specific effects, and to usefully compare functional genomic data across species. Since dsRNA-mediated interference has been shown to be effective in a wide range of plants and animals, the technology opens up the possibility of carrying out RNAi screens in many different eukaryotes. This breaks the monopoly of the 'genetically tractable' few, enabling experimental organisms to be chosen on the basis of their position in the tree of life rather than by reproductive rate or diet. If RNAi libraries can be generated for a wide range of species and cell culture systems, RNAi screens can then be used to explore the changes in the function of genes and pathways that occur through evolutionary time. In addition, it will be possible to compare loss of function studies in in-bred and out-bred populations; a consideration that is of increasing importance as genetic backgrounds are used to inform treatment and diagnostics in the clinic.
It is, of course, difficult to predict how much the data from comparative genome-wide RNAi screens will ultimately alter our view of cells. It seems likely, however, that the ability to carry out systematic loss of function screens in different cell-types conditions and species will encourage a shift to a more global perspective of gene function releasing us from technical limitations, which previously forced us to study the function of each gene or protein in a few specific contexts, (e.g. in a HeLa cell or a developing Drosophila oocyte). Since such a postmodern view of gene function will be difficult to depict, this will necessarily pose new challenges for people in the poster business, and will change the way we look at pathways on our walls.
